Mark S. Rubin
Mark S. Rubin publishes mostly in Oncology, Molecular Biology and Pulmonary and Respiratory Medicine, on topics such as Cancer Diagnosis and Treatment, Melanoma and MAPK Pathways and Lung Cancer Research Studies.
- World rank
- #3,030,054 of 7,710,434 ranked researchers
- Rank in United States
- #868,519 of 1,627,098
- Works
- 16
- Citations
- 722
- Citations per work
- 45.1
What does Mark S. Rubin research?
Mark S. Rubin's work is mostly in Medicine (50%), Biochemistry, Genetics and Molecular Biology (21%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences850.1%
- Medicine850.1%
- Everything else529.1%
- Life Sciences320.8%
- 1Oncology23% of their works
- 2Molecular Biology21% of their works
- 3Pulmonary and Respiratory Medicine10% of their works
- 4Pathology and Forensic Medicine6% of their works
- 5Surgery6% of their works
- 6Epidemiology4% of their works
Research topics
Which keywords describe Mark S. Rubin's research?
The keywords of their largest research topics: Metastasis, Targeted Therapy, Clinical Trials, Cancer of Unknown Primary, Tissue of Origin, ALK Inhibitors, BRAF gene and EGFR Mutations.
- Cancer Genomics
- Signaling
- Immunohistochemical Assessment
- BET Bromodomains
- MAP Kinase
- EGFR Mutations
- ALK Inhibitors
- Cancer of Unknown Primary
- Targeted Therapy
- Metastasis
- Clinical Trials
- Tissue of Origin
- BRAF gene
- Genomic Profiles
- Small-Cell Lung Cancer
- Granular Cell Tumor
- PROTACs
- mTOR
- Mutational Signatures
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 19 words, with their numbers
- Metastasis72 topics
- Targeted Therapy73 topics
- Clinical Trials62 topics
- Cancer of Unknown Primary41 topic
- Tissue of Origin41 topic
- ALK Inhibitors31 topic
- BRAF gene31 topic
- EGFR Mutations31 topic
- Genomic Profiles31 topic
- MAP Kinase31 topic
- Small-Cell Lung Cancer31 topic
- BET Bromodomains21 topic
- Granular Cell Tumor21 topic
- Immunohistochemical Assessment21 topic
- PROTACs21 topic
- Signaling21 topic
- mTOR21 topic
- Cancer Genomics11 topic
- Mutational Signatures11 topic
Where does Mark S. Rubin work?
Mark S. Rubin's main affiliation in the publication record is Sarah Cannon, United States.
How many publications and citations does Mark S. Rubin have?
OpenAlex counts 16 works and 722 citations for Mark S. Rubin, an h-index of 9, ranking #3,030,054 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Mark S. Rubin. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.